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Cell death receptors have crucial roles in the regulation of immune responses. Here we
review recent in vivo data confirming that the Fas death receptor (TNFSR6) on B cells is
important for the regulation of autoimmunity since the impairment of only Fas function
on B cells results in uncontrolled autoantibody production and autoimmunity. Fas plays a
role in the elimination of the non-specific and autoreactive B cells in germinal center, while
during the selection of antigen-specific B cells different escape signals ensure the resis-
tance to Fas-mediated apoptosis. Antigen-specific survival such as BCR or MHCII signal or
coreceptors (CD19) cooperating with BCR inhibits the formation of death inducing signal-
ing complex. Antigen-specific survival can be reinforced by antigen-independent signals of
IL-4 or CD40 overproducing the anti-apoptotic members of the Bcl-2 family proteins.
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INTRODUCTION
Apoptosis may be mediated by intrinsic or extrinsic mechanisms.
Different stimuli such as irradiation, drugs, cytokine deprivation,
DNA damage, anoikis, ER stress, etc., lead to the permeabiliza-
tion of the mitochondrial membrane, activating the intrinsic
pathway. This intrinsic pathway is mainly regulated by the bal-
ance and interaction of the pro- and anti-apoptotic proteins of
the Bcl-2 family. The combined effect of these different factors
determines the amount and the ratio of various members of the
Bcl-2 family and regulates mitochondrial depolarization (Elmore,
2007).
The extrinsic pathways are mediated by cell death receptors,
including the Fas (CD95/Apo-1/TNFSR6) receptor-ligand sys-
tem. Upon the engagement of the cell death receptor by FasL,
Fas rapidly recruits the adapter molecule FADD and caspase-8
proenzyme via interactions with the homologous death domain
(DD) and death effector domain (DED), forming the death-
inducing signaling complex (DISC; Kischkel et al., 1995). This
leads to processing and activation of caspase-8, the initiator cas-
pase. Depending on the amount of activated caspase-8, this pro-
tease can activate the executioner caspases directly (Type-I cells),
or indirectly through the cleavage of Bid (Type-II cells), where the
truncated form of Bid (tBid) dominates the pro-apoptotic part of
the Bcl-2 family, pushing the balance of anti- and pro-apoptotic
proteins toward mitochondrial depolarization. In Type-II cells,
Fas-induced cell death can be inhibited by the upregulation of anti-
apoptotic Bcl-2 proteins, compensating the elevated tBid level.
In Type-I cells, induced cell death can be blocked by the down-
regulation of the number of available receptor molecules (death
receptors/decoy receptor ratio), by the regulation of death recep-
tor aggregation, or by FLIP. FLIP, a caspase-8 homolog (lacking
caspase-8’s protease activity), can block the FADD-caspase-8 asso-
ciation, inhibiting cell death receptor signaling (Scaffidi et al.,
1999).
Evidence accumulated thus far suggests that, apart from the
control of death signaling through the number of receptors and
oligomerization, anti-apoptotic members of the Bcl-2 family can
inhibit the intrinsic pathways in both cell types and only the extrin-
sic pathways of Type-II cells, while FLIP is able to inhibit only
extrinsic pathways, but in both cell types. Pro and pre-B cells as
non-activated lymphocytes die principally by intrinsic pathways,
chiefly through the upregulation of the Bim pro-apoptotic factor.
Accordingly, in these stages of cell development, different survival
signals, such as IL7 or BCR tonic signals trigger elevated levels
of A1 or Mcl-1 anti-apoptotic proteins of the Bcl-2 family (Opfer-
man, 2008). However, upon antigen recognition, immunoreceptor
triggering, cytokines or growth factors (mainly through the reg-
ulation of AKT; Suzuki et al., 2003), the Jak-STAT (Khaled and
Durum, 2003) pathway, and elevated metabolism (Khan, 2009)
strongly push the balance of pro- versus anti-apoptotic members
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of Bcl-2 family toward survival. Therefore activated lymphocytes
must be relatively resistant to the intrinsic apoptotic pathway.
Non-activated B cells express a minimal amount of Fas. How-
ever, upon activation, Fas expression increases. This ensures an
additional and necessary break in the regulation of activated B
cells. Simultaneously, with the emergence of potential Type-I cell
death, FLIP-mediated blockage of Fas-induced signaling becomes
crucial to prevent the unwanted death of activated B cells. With
respect to the survival mechanisms against Fas-mediated cell death
studied in activated B cells, the number of receptors was not
intensively regulated, while the influence of survival signals on
receptor oligomerization has not been systematically investigated.
Our current knowledge suggests that FLIP is a critical regulator of
Fas-mediated B cell death. Elevating FLIP expression results in the
quasi conversion from Type-I to Type-II cells (Verbrugge et al.,
2010) followed by the upregulation of different anti-apoptotic
members of the Bcl-2 family that has been suggested to boost
the survival effect of FLIP. In this review, we summarize the differ-
ent survival signals protecting activated B cells from Fas-induced
cell death.
The IAP family proteins mediate another potential mecha-
nism that inhibits different apoptotic routes. These proteins can
directly block caspase activation. Their very short half-life keeps
the amount of these proteins relatively constant, ensuring the
blockage of unwanted caspase activity, but allowing caspase activ-
ity from different stimuli. The irregular upregulation of any mem-
ber of this family ensures the blockage of apoptosis for only a very
limited period, explaining why survivals signal rarely regulate the
amount of these proteins.
EFFECTS OF B CELL SPECIFIC Fas DEPLETION AND Fas
EXPRESSION ON B CELLS: IN VIVO STUDIES
The interaction between Fas receptor and FasL plays an
essential role in the maintenance of immunological tolerance.
Lack of function mutations in the Fas receptor (e.g., in lpr
mice) or the FasL (gld mice; Takahashi et al., 1994) leads
to immune dysfunction in association with particular genetic
backgrounds. These include lymphadenopathy, splenomegaly,
hyperimmunoglobulinemia, glomerulonephritis, and increased
development of B lymphomas (Watanabe-Fukunaga et al., 1992).
A similar phenomenon has been observed in human Autoimmune
Lymphoproliferative Syndrome (ALPS; Lenardo et al., 2010), most
frequently through various mutations in Fas or in other mole-
cules implicated in Fas-mediated signaling (Fisher et al., 1995;
Rieux-Laucat et al., 1995).
Historically, the most important role of Fas was reported to be
the regulation of T cell activity. However cell type specific dele-
tion of Fas highlighted its crucial role in the cell death process of
different types of cells (including B cells).
Fas was thought to play the main role in T cell regulation based
on the abnormal accumulation of the CD3+B220+CD4−CD8−
T cell population in lpr mice or mice with T cell specific deple-
tion of Fas (Stranges et al., 2007). Nevertheless, in B cell specific
Fas deficient mice, splenomegaly evolved with age without the
appearance of the B220+ DN T cell population (Stranges et al.,
2007; Hao et al., 2008). Similarly, the accumulation of both IgM
and IgG2a producing autoreactive B cells and increased serum
antibody and autoantibody concentrations appear when Fas is
specifically deleted in B cells. In contrast, autoantibody produc-
tion did not occur in T cell specific deletion of Fas (Hao et al., 2004;
Stranges et al., 2007). The elevated levels of autoantibodies result
in hyperimmunoglobulinemia, vasculitis, and glomerulonephritis
(Cohen and Eisenberg, 1991; Shlomchik et al., 1994; Stranges et al.,
2007; Hao et al., 2008). The deposition of immune complexes in
the kidney, lymphocyte infiltration, and tissue destruction in the
liver and lungs leads to lethality in mice of 6–18 months of age in
the absence of Fas.
In these mice, in addition to the emergence of B cells, the B
cell specific depletion of Fas leads to elevated T cell numbers, as
both the exaggerated MHCII expression and the augmented B
cell numbers result in the increased antigen presenting capacity
of B cells (Stranges et al., 2007; Hao et al., 2008). An increased
number of irregular T cell–B cell interactions are formed, concen-
trated mainly in the T cell rich periarteriolar lymphoid sheaths of
the spleen (PALS; Jacobson et al., 1995; Stranges et al., 2007; Hao
et al., 2008) in lpr mice or in mice with B cell specific Fas deletion
(indicating that the number of B cells is regulated mainly in the T
cell rich area in normal mice).
In transgenic lpr/lpr mice, lymphadenopathy was still observed
when functional Fas expression was restored exclusively in B cells.
This is due to the expansion of B220+ T cells. However, the serum
Ig level was comparable with wild type mice, while the serum level
of anti-dsDNA autoantibody was even lower than in normal mice
(Komano et al., 1999). Surprisingly, not only was the autoanti-
body titer limited but antigen-specific responses were also absent,
even after secondary immunization against both T-dependent and
-independent antigens (Komano et al., 1999). The enhanced death
of antigen-specific B cells can be explained by the fourfold greater
lytic activity of T cells in lpr mice compared to normal mice due to
the higher FasL expression (Chu et al., 1995) and the elevated num-
ber of FasL+, DN B220+ T cells in lpr mice (Komano et al., 1999).
(However the different localization of this T cell population and
the abnormally developed B cells make us question the role played
by DN B220+ T cells in cell death of B cells in lpr/lpr mice; Jacob-
son et al., 1995). The unwanted death of antigen-specific B cells by
exaggerated Fas signaling was confirmed with in vitro experiments,
where the “hyperactivation” of Fas with FcγR bound anti-Fas anti-
body disabled antigen receptor-mediated survival (Foote et al.,
1996b).
In summary, in vivo data indicate that while abnormally
intensive Fas/FasL interaction can prevent antigen-specific B cell
responses (Komano et al., 1999), the defect in Fas function results
in uncontrolled autoantibody production, autoimmunity, and
increased risk of B cell lymphomas, revealing that the Fas/FasL
balance must be very accurately regulated during the humoral
immune response.
B CELL SPECIFIC DEPLETION OF FADD, CASPASE-8, AND FLIP
FADD and caspase-8 are indispensible in Fas-mediated apoptosis.
In addition, they contribute to an inhibition of necroptosis, a reg-
ulated RIP1- and RIP3-dependent necrotic cell death form (Van-
denabeele et al., 2010; Han et al., 2012). An elevated necroptosis
due to FADD and caspase-8 deficiencies is associated with embry-
onic lethality in mouse. Thus FADD and caspase-8 deficiencies
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result in a different manifestation from Fas depletion. Blocking the
effect of elevated necroptosis in the double knock-out of caspase-
8 and RIP3 results in viable mice, reminiscent of lpr mice. These
mice contain B220+ T cells and show splenomegaly and lym-
phadenopathy (Oberst et al., 2011) due to abnormally high level
of T cells. Not all aspects of B cell response were investigated in
doubly knock-out mice. B cell development was normal in RIP
and FADD doubly knock-out and the B cells responded normally
to stimulation with anti-IgM.
The role of FADD in B cells could not be concluded in FADD-
knock-out mice due to the organism-wide deficiency. A study
using B cell specific FADD knock down demonstrated that FADD
depleting had no effect on B cell development in the bone marrow,
but resulted in elevated B cell number in the lymphoid organs. Sur-
prisingly the number of B1 cells was significantly reduced (Imtiyaz
et al., 2006). B cells collected from FADD−/−mice were resistant to
recombinant FasL-induced cell death in in vitro culture, indicat-
ing the indispensible role of FADD in Fas-induced signaling in B
cells. However, despite the essential role of FADD in Fas-induced
apoptosis in B cells, mice with B cell specific FADD depletion,
even aged, did not exhibit B cell-related autoimmune diseases
which are characteristic of Fas deficiency. The BCR- and CD40-
induced B cell proliferation was normal in these mice, whereas
TLR3 and TLR4 induced proliferation were markedly decreased
(Imtiyaz et al., 2006).
B cell specific depletion of caspase-8 like the absence of FADD
resulted in elevated B cell number in the spleen, and reduced
amount of B1 cells (Beisner et al., 2005). The BCR, CD40, and
CpG-induced proliferation were unaltered, while TLR3 and TLR4-
generated proliferation was dramatically reduced. Fas-mediated
apoptosis was completely abrogated, but the plasma titer pro-
duced by the caspase-8-deficient B cells against either the T cell-
dependent or independent antigen was unchanged (Beisner et al.,
2005).
Fas-FADD chimera was constructed containing the first 183
amino acids of Fas and the DED of FADD. Expression of this
protein in lymphocytes of MRL-lpr/lpr mice completely dimin-
ishes their T cell abnormalities resulting in the disappearance
of the unusual B220+ T cells representative of Fas deficien-
cies (Kabra et al., 1999). In contrast to T cell discrepancies
B cell-related anomalies were not reconstituted by Fas-FADD
chimera. Reminiscent to lpr/lpr mice serum antibody level and
anti-DNA autoantibody level were higher in Fas-FADD chimera
transgenic mice than in normal mice. This indicates that FADD-
independent Fas-mediated pathway may operate in B cells, but not
in T cells.
Results observed in B cell specific FLIP-deficient mice indicate
that FLIP is dispensable for the development of B cells in the bone
marrow. The numbers of B cells purified from the spleen and
lymph nodes of b-cflip-deficient mice are significantly reduced
when compared with control mice. The data showed that the per-
centages of B1 cells in the absence of FLIP were lower than in
control mice.
While FLIP-deficient B cells can be stimulated with anti-IgM
or CD40 to proliferate, this proliferative response cannot be sus-
tained due to the rapid onset of apoptosis (Coffey and Manser,
2010).
B cells lacking FLIP were more sensitive to Fas-induced apop-
tosis and their participation in the formation of GC responses was
inhibited (Zhang et al., 2009; Coffey and Manser, 2010).
The levels of TNP-specific Ig in FLIP-deficient mice were
lower than in control mice immunized with either the T cell-
independent or the T cell-dependent antigens. In summary FLIP
plays crucial role of Fas-mediated apoptosis in B cells, as well as
in the regulation of B cell number, and in the survival of antibody
producing B cells.
FUNCTION OF Fas IN THE GERMINAL CENTER
The most unambiguous appearance of Fas is within the activated
B cells of germinal centers (GCs; Rathmell and Goodnow, 1995;
Liu et al., 1997; Wang and Watanabe, 1999; Mizuno et al., 2003),
while the expression and function of Fas on other B cells is highly
questionable (Table 1). It is well accepted that Fas expression is
markedly upregulated in activated germinal center B cells both
in mouse and human systems. Fas expression of lymph node or
spleen B cells in vitro and in vivo is markedly increased by PKW,
LPS, and ConA activated T cells and mainly by the CD40L (Mandik
et al., 1995; Onel et al., 1995; Rothstein et al., 1995; Wang et al.,
1996).
Besides the data on Fas expression, functional investigations
confirm that Fas plays a crucial role in GC B cells. Specific deletion
of Fas from GC B cells produces B cell-related discrepancies docu-
mented in lpr mice or in mice with general B cell depletion of Fas,
like elevated serum antibody titer, splenomegaly, lymphoadenopa-
thy without the appearance of abnormal DN T cell population
(Hao et al., 2008). The elevated B cell number was created mainly
by CD38+memory B cells rather than naive or GC B cells.
In GCs during T cell-dependent immune response, anti-
gen recognition by B cells is linked with T cells that recog-
nize the same antigen (Figure 1). The successful presentation
of the B cell’s antigen strengthens the T cell/B cell interac-
tion, which transduces long-term, direct signaling between the
two cells. Because CD40L expression on T cells appears within
a few minutes following antigen stimulation (van Kooten and
Banchereau, 2000), the CD40L-CD40 receptor pair will trig-
ger the B cells to express Fas. CD40 signals launch B cell
proliferation, differentiation, germinal center development, iso-
type switching, etc. (reviewed in Bishop and Hostager, 2003).
In addition to inducing Fas expression, CD40 signals pro-
vide a potential restraining mechanism to prevent the hyper-
activity of humoral immune responses. In the following parts
of this review we will summarize the survival signals rescu-
ing the germinal center B cells from Fas-mediated cytotoxicity
(Figure 2).
ANTIGEN-SPECIFIC SURVIVAL SIGNALS AND INHIBITION OF
Fas-INDUCED CELL DEATH
BCR
The FasL-induced stimulation by antigen-specific T cells can kill
germinal center B cells unless a survival signal is received. The
main rescue signal is transduced by BCR upon recognition of the
antigen (extensively reviewed in Wang and Watanabe, 1999; Roth-
stein, 2000; Mizuno et al., 2003), such that Fas can only induce
cell death in B cells with an impaired BCR signaling capacity or
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Table 1 | Expression and function of Fas and sensitivity to Fas-induced cell death in different B cell populations.
Cell type Human Mouse
B1 cells Expression Negative, CD40 stimulation upregulates Fas
expression and induces a biphasic profile (Huck et al.,
1998; Kodama et al., 2001)
Negative, LPS stimulation upregulates Fas expression
(Mandik et al., 1995) and induces a biphasic profile (Hirose
et al., 1997; reviewed in Wang and Watanabe, 1999)
Function Biphasic sensitivity (Kodama et al., 2001) Hardly susceptible (Masuda et al., 1997), Function in
autoantibody production in lpr mice (Watanabe et al., 2002;
Qian et al., 2006) biphasic sensitivity (Hirose et al., 1997)
Mantle zone Expression Negative, inducible? (Leithauser et al., 1993; Moller
et al., 1993; Yoshino et al., 1994; Tsunoda et al., 2000)
No data
Function Participation in autoantibody production (Qian et al.,
2006)
No data
Pre, pro,
immature
Expression Weak (Nishiuchi et al., 1996; Nilsson et al., 2000) Weak, positive (Mandik et al., 1995; Onel et al., 1995)
Function Resistant (Nishiuchi et al., 1996; Nilsson et al., 2000)
debated in Lanvin et al. (2003)
Resistant (Mandik et al., 1995; Onel et al., 1995)
Blood Expression 5–25% positive (Miyawaki et al., 1992; Daniel and
Krammer, 1994), PKW (Daniel and Krammer, 1994;
Yoshino et al., 1994), IL2+ aIgM induces (Huck et al.,
1998)
Partially positive, LPS induces (Wang et al., 1996)
Function Resistant (Yoshino et al., 1994) sensitive upon
upregulation (Daniel and Krammer, 1994)
Resistant (Wang et al., 1996)
Memory Expression Low positivity (Liu et al., 1995; Choe et al., 1996;
Lagresle et al., 1996)
Low positivity (Tsunoda et al., 2000; Takahashi et al., 2001)
Function Resistant (Liu et al., 1995; Choe et al., 1996; Lagresle
et al., 1996; high BCL-2 expression)
Resistant (Tsunoda et al., 2000; Takahashi et al., 2001; high
BCL-2 expression)
Plasma cells Expression Tonsil: positive (Choe et al., 1996), negative (Moller
et al., 1993; Merville et al., 1996) in bone marrow:
weakly positive (Nishiuchi et al., 1996)
Weak positivity upon immunization in spleen (Smith et al.,
1995)
Function Leukemia or myeloma cells unclear results (Shima
et al., 1995; Sampalo et al., 2000)
No data
For germinal center cells, see the text.
diminished antigen recognition. In accordance with the theory
regarding the regulation of B cell homeostasis, the Fas receptor
induces cell death in tolerant B cells upon the desensitization of
BCR signaling (Goodnow, 1996) and plays a role in the elimi-
nation of the non-specific and autoreactive B cells, generated by
somatic mutations that take place in the germinal center (Taka-
hashi et al., 2001; Hao et al., 2008; Ait-Azzouzene et al., 2010)
(Figure 1). This selection process will lead to the death of the
non-specific or non-responsive (anergic) B cells (Rathmell et al.,
1995, 1996; Rothstein et al., 1995), while specific B cells become
plasma cells, memory cells, or re-enter into the germinal center
cycle again.
Different signaling pathways were considered regarding the
regulation of the BCR-transduced survival signals (Table 2).
MHC II
Beside antigen recognition by B cells, TCR-MHC interaction
requires the specificity of the adaptive immune response. B cells
are effective antigen presenting cells capable of initiating cell–cell
interactions with T cells. In the B cell–T cell pair TCR-MHC-
interactions ensure the common specificity of the two cells,
guaranteeing that the correct antigen is presented to the specific T
cells. Without BCR-mediated uptake, processing, and presentation
of the adequate antigen by B cells long-term B cell–T cell linkage
cannot be created. The prolonged T cell–B cell interaction also
increases the potential Fas-FasL interaction time. The importance
of the antigen presentation in Fas-mediated cell death of B lym-
phocytes was clearly confirmed when peptide fragments of HEL
antigen were loaded into B cells. Since B cells recognized only the
whole antigen and not the fragments the BCR-transduced survival
was inactive, but the antigen presenting capacity remained normal
with respect to the peptide specific T cells. In this model, antigen
presenting B cells were killed by the HEL specific T cells. With-
out the peptide loading (without the antigen presenting capac-
ity), the B cells survived (Rathmell et al., 1996; Janssens et al.,
2003).
Beyond the ability to trigger the T cells, MHCII is capa-
ble of transducing its own (reverse) signals, and consequently
triggering B cell activation (Scholl and Geha, 1994; Al-Daccak
et al., 2004). Several studies investigated the effect of MHCII-
mediated signaling on Fas-induced apoptosis, but the impact of
MHCII-transduced signals on Fas-induced cell death is debated.
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A B
C D
FIGURE 1 | Four different types ofT cell–B cell interaction can occur in
the germinal center: (A) following antigen recognition the specific B cells
express Fas and in time became capable of presenting antigen to
antigen-specificT cells. Strong affinity B cells maintain their antigen
specificity during somatic mutation and as a consequence the BCR
transduces signals even during competition for the limited available antigen.
The BCR-mediated survival signals compete with Fas-induced cell death. (B)
The naive (bystander) B cells do not interact with activated, FasL-expressing T
cells in the absence of presentation of the appropriate antigen. In this
situation their Fas expression is also very limited. As mentioned above, these
cells are not targets of Fas-induced cell death. (C) The low affinity B cells, and
B cells which lost antigen-specificity because of somatic mutation, are first
targets of Fas-mediated killing. Maintaining antigen presenting capacity, but
losing antigen triggering in the competition for the antigen, these cells
contact the T cells, but do not access the survival signal. This explains the
elevated antibody level in lpr mice where the antigen non-specific B cells can
survive. (D) Anergic B cells are the main targets of Fas-mediated killing; the
antigen receptor signaling of anergic B cells is desensitized due to their
permanent activation. This group can explain the enhanced autoantibody
production observed in lpr mice.
FIGURE 2 | Survival signals rescuing Fas-induced apoptosis in B cells.
Using different cell lines, pre-treatment with agonistic anti-MHCII
antibodies before anti-Fas addition enhances the cell death inten-
sity in case of immature and blastoid B cell lines, but has no effect
on plasmacytic cell lines (Yoshino et al., 1995; Blancheteau et al.,
2002). In contrast, results obtained with mouse spleen B cells and
the A20 B cell line indicate that simultaneous MHCII signals with
Fas triggering protect the B cells from Fas-stimulated cell death
(Catlett et al., 2001), but 24–96 h pre-treatment of anti-MHCII
increased the Fas-mediated cell death, at least partially because,
surprisingly, it induced FasL expression on the B cells (Truman
et al., 1997).
Due to the divergent functional data, conflicting results have
been published concerning the effect of MHCII on the Fas-
mediated signaling pathway (Table 2). In A20 mouse B cell line,
the MHCII signal had no influence on Fas/Fadd association, but
reduced the caspase-8 activity and cell death (Catlett et al., 2001).
In contrast on LAD human B cell line, a 30-min pre-treatment of
MHCII by enhancing the FADD recruitment to the Fas receptor,
augments the caspase cleavage and cell death (Blancheteau et al.,
2002). Regrettably all above experiments were performed by usage
of anti-MHCII antibodies, without studying the direct T cell–B
cell connection.
CORECEPTORS
Accumulated evidence suggests that other signals that are not
directly implicated in antigen recognition may modify the BCR-
mediated survival. CD19, a positive coreceptor of the BCR, reduces
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Table 2 | Detailed molecular mechanism of inhibition of Fas-induced cell killing.
BCR MHCII CD19 CD40 IL-4 FDC CpG
Fas expression Unchanged/increased
(Garrone et al., 1995;
Rathmell et al., 1995;
Rothstein et al., 1995; Foote
et al., 1996b; Nakanishi et al.,
1996; Bras et al., 1997;
Schneider et al., 1997;
Tumang et al., 2002; Schram
and Rothstein, 2003;
Moriyama and Yonehara,
2007)
Decreased (Choe et al., 1996;
Lagresle et al., 1996)
Not altered
(Yoshino et al.,
1995; Catlett
et al., 2001;
Blancheteau
et al., 2002)
Not decreased
(Barrington
et al.,
2005)/decreased
(Mongini
et al., 2003)
Upregulated
(Garrone et al.,
1995; Lagresle
et al., 1995;
Onel et al.,
1995; Rathmell
et al., 1995;
Schattner
et al., 1995;
Wang et al.,
1996)
Unchanged/
increased
(Foote et al.,
1996a;
Koizumi et al.,
1996;
Nakanishi
et al., 1996;
Wurster et al.,
2002)
Upregulated
(Tsunoda et al.,
2000)
Decreased
(Wang et al.,
1997)
Not decreased
(Hancz et al.,
2012)
DISC level Reduced (Catlett and Bishop,
1999)/not changed (Carey
et al., 2000; Wang et al.,
2000) FADD association
Reduced caspase-8
association (Wang et al.,
2000)
Reduced caspase-8 cleavage
(Bras et al., 1997; Catlett and
Bishop, 1999; Hinshaw et al.,
2003; Moriyama and
Yonehara, 2007)
Transient upregulation of FLIP
(Wang et al., 2000; Hennino
et al., 2001; Owyang et al.,
2001; Schram and Rothstein,
2003; Moriyama and
Yonehara, 2007)
FLIP silencing leads to Fas
sensitivity (Moriyama and
Yonehara, 2007)
FLIP overexpression leads to
resistance (Wang et al., 2000)
Reduced
caspase-8
activity (Catlett
et al., 2001)
Elevated
caspase-8
cleavage
(Blancheteau
et al., 2002)
Reduced
caspase-8
cleavage
(Mongini
et al., 2003)
Upregulation
of FLIP
(Mongini et al.,
2003;
Barrington
et al., 2005)
Not changed
Fadd
association
(Benson et al.,
2006; Eeva
et al., 2007)
Decreased
caspase-8
activation
(Benson et al.,
2006; Eeva
et al., 2007)
Flip expression
is upregulated
(Hennino
et al., 2000,
2001; Eeva
et al., 2007)
Reduced
caspase-8
activity (van
Eijk et al.,
2001b) without
FDC FLIP
expression
decays
(Hennino
et al., 2001)
presence of
FDC restore
FLIP
expression
(van Eijk et al.,
2001b)
Reduced
caspase-8
activity (Hancz
et al., 2012)
Mitochondria Transient upregulation of
Bcl-xl (Choe et al., 1996;
Koizumi et al., 1996;
Schneider et al., 1997;
Owyang et al., 2001; Tumang
et al., 2002; Schram and
Rothstein, 2003)
Bfl-1 upregulation (Tumang
et al., 2002)
Effective survival without
upregulation of Bcl-xl (Alam
et al., 1997; Owyang et al.,
2001; Hinshaw et al., 2003;
Moriyama and Yonehara,
2007)
Overexpression of Bcl-xl does
not display absolute survival
(Schneider et al., 1997)
Upregulation
of Bcl-2
(Mongini et al.,
2003)
Bcl-2 was not
changed in
(Barrington
et al., 2005)
Bfl-1, A1,
Bcl-xl
upregulated
(Lee et al.,
1999)
Upregulated
Bcl-xl (Wurster
et al., 2002)
marginal Bcl-xl
upregulation
(Schneider
et al., 1997)
Bcl-2, Bcl-xl,
Bax amount
was
unchanged
(Schwarz et al.,
1999; Tsunoda
et al., 2000)
(Continued)
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Table 2 | Continued
BCR MHCII CD19 CD40 IL-4 FDC CpG
Other Upregulation of FAIM, which
results in the increase of FLIP
expression (Schneider et al.,
1999; Owyang et al., 2001;
Huo et al., 2009)
Gadd45β
upregulation
(Zazzeroni
et al., 2003)
Bold font, human; normal font, mouse.
Human: BCR (Garrone et al., 1995; Choe et al., 1996; Lagresle et al., 1996; Hennino et al., 2001; Alam et al., 1997), MHC (Yoshino et al., 1995; Blancheteau et al.,
2002), CD19 (Mongini et al., 2003), CD40 (Garrone et al., 1995; Lagresle et al., 1995; Schattner et al., 1995; Benson et al., 2006; Hennino et al., 2000; Lee et al., 1999;
Hennino et al., 2001), FDC (Tsunoda et al., 2000; van Eijk et al., 2001b; Hennino et al., 2001).
the required threshold for B cell activation. Published data indi-
cate that either positive (CD19) or negative coreceptors (FcγRIIb,
CD22) modify the strength or the threshold of the BCR signaling.
Among them, the effect of CD19, the signaling part of complement
receptor 2 (CD21) was studied as a regulator of Fas-induced cell
death. It is well known that coactivation of BCR with CD19 reduces
the threshold of anti-IgM signaling 10- to 100-fold (Carter and
Fearon, 1992), attracting attention to the importance of the com-
plement system in the immune complex. In accordance with these
results, recombinant antigen fused with the C3d3 complement
component reduced 100-fold the amount of antigen necessary for
50% protection against anti-Fas-induced cell death (Barrington
et al., 2005). Further confirming the role of complement frag-
ments in survival signals, increased apoptosis was observed in
CR2−/− B cells, but not in CR2−/− lpr mice (Barrington et al.,
2005). The intensively triggered CD21 alone is capable of gener-
ating partial survival (Mongini et al., 2003) and co-stimulation of
the anti-CD21 with anti-IgM enhancing protection against Fas-
induced cell death (Mongini et al., 2003). The exact signaling of
this effect is not clear (Table 2). Coactivation of CD21 and BCR
in human tonsillar B cells decreased Fas expression upon CD40
stimulus, increase the levels of anti-apoptotic Flip and Bcl-2 (but
not BCL-xl) and reduced caspase-8 cleavage when compared to
BCR activation alone (Mongini et al., 2003) However activation of
mouse B cells by recombinant antigen fused with C3d3 resulted in
only an increase in expression level of FLIP but not Bcl-2. Similarly
antigen stimulation of CR2−/−mice resulted in normal Fas expres-
sion and reduced amount of FLIP but not BCL-2 (Barrington et al.,
2005).
NON-ANTIGEN-SPECIFIC SURVIVAL SIGNALS
Antigen-independent (non-specific) B cells, in which activating
signals do not markedly alter the balance of anti- and pro-
apoptotic proteins toward survival, can be a target of Bcl-2
regulated escape from Fas-induced cell death.
CD40
CD40 is one of the most important coreceptors of B cells, playing
a crucial role in the stimulation of B cell proliferation, inducing
somatic mutation and class switch. The main source of the B cell
stimulating CD40L is derived from activated T cells, but den-
dritic cells and germinal center B cells (Grammer et al., 1995,
1999) also carry the ligand. Upon triggering, CD40 upregulates
Fas expression in both naive, germinal center, and memory B cells
and facilitates the apoptotic death of stimulated cells. CD40L is
fully involved in the induction of Fas in anergic B cells. In spe-
cific B cells, due to the more intensive BCR signaling, CD40L is
only partially responsible for Fas upregulation (Rathmell et al.,
1996). Besides Fas upregulation, the CD40L-induced stimulus,
alone (Cleary et al., 1995; Hennino et al., 2000), or synergistically
with the BCR signal (Koopman et al., 1997; Lee et al., 1999; Hen-
nino et al., 2000; Zazzeroni et al., 2003; Ho et al., 2005; Kater et al.,
2005; Benson et al., 2006; Eeva et al., 2007), provides a short term
(1 to maximum 2 days) rescue signal against Fas-induced death
(reviewed in Guzman-Rojas et al., 2002). Several publications
explain this survival signal (Table 2).
1. The assembly of DISC in mouse and human B cell lines is
regulated by CD40 signals. Resembling the BCR-mediated sur-
vival signal several articles presented that CD40 stimulation
decreased the caspase-8 and caspase-3 activation, and the col-
lapse of mitochondrial membrane potential but did not affect
FADD-Fas association (Benson et al., 2006; Eeva et al., 2007).
2. The CD40-mediated upregulation of anti-apoptotic proteins
delay the onset of the Fas-induced cell death. Both Flip short
and long forms were upregulated in 4–24 h after CD40 stimu-
lation and decrease thereafter reaching their lowest levels after
72 h (Hennino et al., 2000; Eeva et al., 2007). NFκB activation
played crucial role on FLIP overexpression since its inhibi-
tion blocked the CD40-induced Flip overexpression (Hennino
et al., 2000; Eeva et al., 2007). Results from different human
cell lines showed that anti-apoptotic members of Bcl-2 fam-
ily, Bfl-1/A1, and Bcl-xl, were upregulated by CD40. RNA of
Bcl-xl and Bfl-1 are induced in 4–8 h following CD40 stimula-
tion. The transcriptions of these anti-apoptotic proteins upon
CD40 activation were completely abolished in the presence of
constitutive IkB mutant, where exogenous Bcl-xl could restore
the resistance to Fas-mediated cell death (Lee et al., 1999).
In the presence of CD40L different B cell lines and primary
splenocytes upregulated Gadd45β expression in an hour, much
earlier than the observable increase in the expressions of Bcl-xl
and Flip. Overexpression of this protein, in the level comparable
with normal cells upon CD40 activation (Zazzeroni et al., 2003),
led to Fas resistance. Gadd45β inhibited the caspase activation and
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the mitochondrion depolarization, but neither the DISC forma-
tion, nor the early times Bid cleavage. These result suggest that
Gadd45β inhibited the caspase activation following the activation
of mitochondrial pathway (Zazzeroni et al., 2003).
ADHESION, CELL–CELL CONTACT
B cell contact either with T cells or with follicular dendritic cells
influences Fas-induced cell death. In the case of antigen-specific
T and B cell interaction, upon the formation of a T cell–B cell
connection mediated by MHCII and the specific TCR, adhesion
molecules reinforce T cell–B cell linkage, keeping the two cells in
contact. Inhibition of the most prominent adhesion molecule pair,
LFA1-ICAM1 by anti-LFA1 or an anti-ICAM1, completely blocked
the cell death of target B cells (Wang and Lenardo, 1997) while
the anti-CD2, anti-CD48 antibodies have weaker but significant
effects. Because none of these antibodies directly affected anti-Fas-
mediated lysis, the critical importance of the cell–cell contact time
between the FasL-expressing T cells and Fas-positive target cells is
suggested (Wang and Lenardo, 1997). Thus antigen-specific T cells
fail to lyse B cells in the absence of long-term Fas-FasL signaling
(Wang and Lenardo, 1997).
B7.2
The expression of the prominent co-stimulatory molecule B7.2
is repressed in anergic B cells (Ho et al., 1994; Lenschow et al.,
1994). In B7.2 transgenic mice, where the expression level of
B7.2 in anergic B cells was restored and thus comparable with
the level that is normally present on antigen-sensitive responding
B cells, T cells did not kill the anergic B cells with appropriate
antigen specificity (Rathmell et al., 1998). However, in vitro, B7.2
transgenic and normal anergic B cells were equally sensitive to anti-
Fas-induced cell death. The survival effect of the co-stimulatory
molecule was mediated by upregulated IL-4 production, which
was only detectable upon the cooperation of antigen-specific T
cells and B cells with high B7.2 expression and not in the case of
B7.2 non-expressing B cells (Rathmell et al., 1998). In contrast,
others found that blocking antibodies to B7.1 and B7.2 had no
effect on CD4 T cell-induced cell death of normal, non-anergic B
cells (Wang and Lenardo, 1997).
FDC
GC B cells undergo apoptosis at least partially in a caspase-
dependent manner when detached from their microenvironment
(Lindhout et al., 1995). This process does not require any inducing
death receptor signal, but Fas signaling accelerates this cell death
route (van Eijk et al., 2001b). FasL-independent organization of
preformed DISC and constant association of FADD, caspase-8,
and FLIPL with Fas were found in freshly isolated GC B cells.
Accordingly, caspase-8 activation was observed within 40 min of
the detachment of GC B cells without the need of Fas ligation
(Hennino et al., 2001).
In the presence of FDC, GC B cells are protected from apopto-
sis, even after Fas activation both in mouse (Schwarz et al., 1999)
and human systems (Lindhout et al., 1995; Koopman et al., 1997;
van Eijk et al., 2001a), regardless of the fact that the presence of
FDC enhances Fas expression in B cells (Tsunoda et al., 2000) and
that FDC in the germinal center express FasL (Verbeke et al., 1999).
How the coculture with FDC is capable of inhibiting anti-Fas-
generated cell death in B cells is not fully understood, but FLIP
seems to be the crucial actor in this process (Schwarz et al., 1999).
IL-4
Beside direct cell–cell contact, B cell survival is regulated by inter-
leukins. Addition of IL-4 to CD40L-stimulated B cells reduces
Fas-induced apoptosis (Foote et al., 1996a, 1998; Koizumi et al.,
1996; Nakanishi et al., 1996; Wurster et al., 2002). The IL-4-
generated resistance was synergistic with CD40L mediated survival
(Nakanishi et al., 1996). Using suboptimal doses of anti-IgM,
IL-4 was found to be strongly synergistic with BCR-transduced
rescue signals (Foote et al., 1996a). However, the signaling mecha-
nism utilized by IL-4 for Fas resistance differed from that used by
IgM: first, the time required for IL-4-induced survival signal was
longer than the one mediated by BCR (12–24 h); second, the IL-4
driven pathway whereas PKC independent (Foote et al., 1996a)
absolutely required STAT6; third, through STAT6 activation IL-4
directly upregulated the Bcl-xl level (Wurster et al., 2002). One
can note that some authors detected only marginal IL-4-induced
upregulation of Bcl-xl (Schneider et al., 1997).
Unfortunately the CD40-independent survival potential of IL-4
signaling has not been yet investigated. From this study, the effect
of overproduced Bcl-xl cannot be dissociated from the elevated
FLIP level due to CD40 signaling. Upon upregulation of FLIP by
BCR or CD40 signaling, Bcl-xl can clearly inhibit the Fas-mediated
cell death pathway. However, the question remains as to whether
the IL-4-induced upregulation of Bcl-xl alone is able to reduce
Fas-induced cell death in B cells. Nonetheless, the most important
consequence of this effect is that IL-4 transduced survival signal-
ing, as non-antigen-specific signaling was not impaired in tolerant
B cells while the BCR-induced survival signal did not function in
these cells (Foote et al., 1998). The IL-4 signaling, by inhibiting the
mitochondrial pathway, is able to keep the anergic B cells alive.
CpG
Hypomethylated bacterial DNA contains a high percentage of
CpG motifs that activate 95% of resting B cells. CpG contain-
ing oligonucleotides were found to effectively protect CD40L-
stimulated B cells from CD4+ T cell-mediated apoptosis but
had no effect on IgM-induced resistance (Wang and Lenardo,
1997). The CpG-triggered signaling pathways have not been exten-
sively characterized (Table 2). Coligation of TLR9 and BCR pro-
motes auto-antigen-specific B cell responses (Chaturvedi et al.,
2008). This signaling pathway can break BCR tolerance and
thereby rescue autoreactive but anergic B cells from Fas-mediated
apoptosis.
FURTHER QUESTIONS
Our knowledge about the role of Fas in T-independent B cell
responses is very limited. In the absence of T cell–B cell inter-
action, the potential for Fas-FasL interaction remains unknown.
However the control of activated B cells is also crucial in this type
of response. The B1 cell population has been suggested as FasL
targets (see Table 1), but the source of FasL is still unknown.
As long-term T cell–B cell interaction requires common
antigen-specificity, self-reactive B cells are probably not killed by T
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cells specific for external antigen. The role of Treg cells would be a
very interesting aspect of MHCII-Fas interaction. Treg cells are key
actors of peripheral tolerance to self-antigen. The expression and
function of FasL was established in this immunosuppressive cell
population (Baatar et al., 2007). Treg cells may eliminate autore-
active B cells through prolonged FasL-Fas triggering due to direct
MHCII-TCR interaction (Janssens et al., 2003). Otherwise, in the
absence of prolonged self-reactive B cell–T cell interactions, the
killing of self-recognizing B cells, and the elevated number of
autoimmune B cells in lpr mice would not be explained.
Fas aggregation, raft localization, and cytoskeleton association
may be the targets of a survival pathway but little has been pub-
lished about the BCR-mediated, protein-synthesis-independent,
regulation of Fas signaling. Some authors have reported that BCR-
mediated survival was absolutely dependent on protein synthesis
(Foote et al., 1996b; Schneider et al., 1997) while others using the
A20 cell line found that this effect was almost fully incomplete
(Catlett and Bishop, 1999; Hinshaw et al., 2003). Based on Bras
theory (Bras et al., 1997) two independent, but additive pathways,
a prompt PKC-regulated and a time dependent NFκB directed,
protein-synthesis-dependent pathway may collaborate in BCR-
mediated survival. PKC could inhibit the very early, necessary step
of Fas activation. Receptor aggregation (in Jurkat cells; Ruiz-Ruiz
et al., 1999) and PKCζwas mentioned as a component of the DISC
with inhibitory capacity (Leroy et al., 2005). A similar mechanism
is supposed for B cells, explaining the reduced DISC formation
upon BCR-induced PKC activation.
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